Wednesday, September 19, 2012

Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 92 Issue 4


TABLE OF CONTENTS

Volume 92, Issue 4 (October 2012)

In this issue
In This Issue
Editorial
News & Views
Perspectives
Discovery & Development
Regulation & Use
Clinical Trial
State of the Art
Research

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement




A new online open access journal from Clinical Pharmacology & Therapeutics.
Sign me up for this alert

Publishing advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans with a common focus on the application of these two areas on drug development.
 

In This Issue

Top

In This Issue

Clin Pharmacol Ther 2012 92: 399; 10.1038/clpt.2012.161

Full Text

Editorial

Top

Achieving the Promise of Personalized Medicine

K S Reynolds

Clin Pharmacol Ther 2012 92: 401-405; 10.1038/clpt.2012.147

Abstract | Full Text

News & Views

Top


Highlights

Clin Pharmacol Ther 2012 92: 406-407; 10.1038/clpt.2012.160

Full Text


ASCPT News

Clin Pharmacol Ther 2012 92: 408-410; 10.1038/clpt.2012.148

Full Text

Perspectives

Top

COMMENTARIES

Without an Adequate Ethical Infrastructure, the Road to Personalized Medicine Will Be Rocky at Best

A L Caplan

Clin Pharmacol Ther 2012 92: 411-412; 10.1038/clpt.2012.142

Abstract | Full Text

Ready When You Are: Easing Into Preemptive Pharmacogenetics

Y J He and H L McLeod

Clin Pharmacol Ther 2012 92: 412-414; 10.1038/clpt.2012.144

Abstract | Full Text

Pharmacogenomics Knowledge for Personalized Medicine

M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman and T E Klein

Clin Pharmacol Ther 2012 92: 414-417; 10.1038/clpt.2012.96

Abstract | Full Text

Individualized Dosing With Anesthetic Agents

H J M Lemmens and D R Stanski

Clin Pharmacol Ther 2012 92: 417-419; 10.1038/clpt.2012.131

Abstract | Full Text

In Search of Physiologically Based Distribution Volume Estimates for Macromolecules

P D Garzone and A J Atkinson, Jr.

Clin Pharmacol Ther 2012 92: 419-421; 10.1038/clpt.2012.156

Abstract | Full Text

Discovery & Development

Top

DISCOVERY

Population Imaging as Valuable Tool for Personalized Medicine

H Völzke, C O Schmidt, K Hegenscheid, J-P Kühn, F Bamberg, W Lieb, H K Kroemer, N Hosten and R Puls

Clin Pharmacol Ther 2012 92: 422-424; advance online publication, August 22, 2012; 10.1038/clpt.2012.100

Abstract | Full Text


Clinical Translation of Cell-Based Pharmacogenomic Discovery

N J Cox, E R Gamazon, H E Wheeler and M E Dolan

Clin Pharmacol Ther 2012 92: 425-427; advance online publication, August 22, 2012; 10.1038/clpt.2012.115

Abstract | Full Text

The Relevance of “Missing Heritability ” in Pharmacogenomics

W Sadee

Clin Pharmacol Ther 2012 92: 428-430; advance online publication, August 22, 2012; 10.1038/clpt.2012.116

Full Text

TRANSLATION

Individualization of Tamoxifen Treatment for Breast Carcinoma

L Binkhorst, T van Gelder and R H J Mathijssen

Clin Pharmacol Ther 2012 92: 431-433; advance online publication, August 22, 2012; 10.1038/clpt.2012.94

Abstract | Full Text

Interpreting Pharmacogenetic Data in the Developing Neonate: The Challenge of Hitting a Moving Target

J S Leeder and G L Kearns

Clin Pharmacol Ther 2012 92: 434-436; advance online publication, September 5, 2012; 10.1038/clpt.2012.130

Abstract | Full Text

Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array

J A Johnson, B M Burkley, T Y Langaee, M J Clare-Salzler, T E Klein and R B Altman

Clin Pharmacol Ther 2012 92: 437-439; advance online publication, August 22, 2012; 10.1038/clpt.2012.125

Abstract | Full Text

DEVELOPMENT

Progress Toward Personalized Treatment of Rheumatoid Arthritis

M P Keith, J D Edison and W R Gilliland

Clin Pharmacol Ther 2012 92: 440-442; advance online publication, August 22, 2012; 10.1038/clpt.2012.124

Abstract | Full Text

Regulation & Use

Top

PRACTICE

Strategies for Personalized Medicine–Based Research and Implementation in the Clinical Workflow

W Lieb, H Völzke, J M Pulley, D M Roden and H K Kroemer

Clin Pharmacol Ther 2012 92: 443-445; advance online publication, August 22, 2012; 10.1038/clpt.2012.119

Abstract | Full Text

The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics

P H O'Donnell, A Bush, J Spitz, K Danahey, D Saner, S Das, N J Cox and M J Ratain

Clin Pharmacol Ther 2012 92: 446-449; advance online publication, August 29, 2012; 10.1038/clpt.2012.117

Abstract | Full Text

Clinical Trial

Top

The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial

A Marquet, K Kupas, A Johne, B Astruc, A Patat, S Krösser and A Kovar

Clin Pharmacol Ther 2012 92: 450-457; advance online publication, September 5, 2012; 10.1038/clpt.2012.128

Abstract | Full Text

State of the Art

Top

Individualization of Drug Therapy: History, Present State, and Opportunities for the Future

L J Lesko and S Schmidt

Clin Pharmacol Ther 2012 92: 458-466; advance online publication, September 5, 2012; 10.1038/clpt.2012.113

Abstract | Full Text

Pharmacogenomics and Individualized Medicine: Translating Science Into Practice

K R Crews, J K Hicks, C-H Pui, M V Relling and W E Evans

Clin Pharmacol Ther 2012 92: 467-475; advance online publication, September 5, 2012; 10.1038/clpt.2012.120

Abstract | Full Text

Personalizing Antiplatelet Therapy With Clopidogrel

D Trenk, O Zolk, M F Fromm, F-J Neumann and W Hochholzer

Clin Pharmacol Ther 2012 92: 476-485; advance online publication, September 5, 2012; 10.1038/clpt.2012.133

Abstract | Full Text

Advancing the Science of Medicines Regulation: The Role of the 21st-Century Medicines Regulator

M M Lumpkin, H-G Eichler, A Breckenridge, M A Hamburg, T Lönngren and K Woods

Clin Pharmacol Ther 2012 92: 486-493; advance online publication, September 5, 2012; 10.1038/clpt.2012.146

Abstract | Full Text

Research

Top

ARTICLES

Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model

M Siccardi, L Almond, A Schipani, C Csajka, C Marzolini, C Wyen, N H Brockmeyer, M Boffito, A Owen and D Back

Clin Pharmacol Ther 2012 92: 494-502; advance online publication, July 18, 2012; 10.1038/clpt.2012.61

Abstract | Full Text

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

K Eechoute, A A M van der Veldt, S Oosting, M H W Kappers, J A M Wessels, H Gelderblom, H-J Guchelaar, A K L Reyners, C M L van Herpen, J B Haanen, R H J Mathijssen and E Boven

Clin Pharmacol Ther 2012 92: 503-510; advance online publication, September 5, 2012; 10.1038/clpt.2012.136

Abstract | Full Text

Influence of Environmental and Genetic Factors on CYP1A2 Activity in Individuals of South Asian and European Ancestry

V Perera, A S Gross and A J McLachlan

Clin Pharmacol Ther 2012 92: 511-519; advance online publication, September 5, 2012; 10.1038/clpt.2012.139

Abstract | Full Text

Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer

V L Chudasama, F Schaedeli Stark, J M Harrold, J Tibbitts, S R Girish, M Gupta, N Frey and D E Mager

Clin Pharmacol Ther 2012 92: 520-527; advance online publication, September 12, 2012; 10.1038/clpt.2012.153

Abstract | Full Text

Advertisement
Ensure your access If you are unable to access the articles in thisalert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeProdRequest?id=clpt
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: